Recent advancements in anti-obesity medications, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro), have demonstrated significant weight loss benefits with minimal side effects. These drugs suppress appetite and improve metabolic health, offering a promising solution to combat obesity-related conditions like type 2 diabetes and heart disease.
Brought to you by Healthwise Feed’s “Daily Picks” team. Curated from credible health sources.
👉 Follow us @healthwisefeed1 for more wellness tips and updates.
In the UK, the National Institute for Health and Care Excellence (NICE) has approved these treatments for approximately 3.4 million adults. However, due to capacity constraints within the NHS, only about 220,000 patients are expected to receive them over the next three years.
This raises equity concerns—particularly for low-income individuals who may not afford private care. While these medications bring real health benefits, experts stress the importance of medical supervision and tight regulation to prevent misuse for cosmetic weight loss.
Source: The Times